A team of researchers at Kobe Gakuin University in Japan have genetically engineered insulin-fused proteins capable of targeting hippocampal neurons. The innovative technique capitalizes on insulin’s natural tendency to accumulate in the hippocampal neuronal tissue. This new approach could unlock existing treatments for neurodegenerative disorders such as Alzheimer’s disease by allowing existing drugs to be delivered on target.
This article was originally published on MedicalXpress.com
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
© 2024 SimplyWell.ca